SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
January 9, 2003
--------------------------------------------------------------------------------
(Date of earliest event reported)
ABIOMED, Inc.
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-20584 04-2743260
--------------------------------------------------------------------------------
(State or other (Commission File Number) (IRS Employer
jurisdiction Identification No.)
of incorporation)
22 Cherry Hill Drive, Danvers, Massachusetts 01923
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
(978) 777-5410
--------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
Not Applicable
--------------------------------------------------------------------------------
(Former name, former address and former fiscal year,
if changed since last report)
ITEM 5. OTHER EVENTS.
On January 9, 2003, ABIOMED, Inc. issued a Press Release announcing the
resignation of John F. Thero, its Chief Financial Officer. A copy of the Press
Release is set forth in Exhibit 99.1 and is incorporated by reference herein.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(a) Exhibits
99.1 January 9, 2003 Press Release
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ABIOMED, Inc.
By: /s/ DAVID M. LEDERMAN
----------------------------------------
David M. Lederman
Chief Executive Officer and President
Date: January 9, 2003